Company profile
Quantitative Digital Pathology Services | OracleBio
A leading contract research organisation (CRO) specialising in quantitative digital pathology services to support Pharma R&D.
Financial period: 1 Apr 2024 to 31 Mar 2025
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
1 Apr 2023 to 31 Mar 2025
Bowel cancer screening is used to find bowel cancer and pre-cancerous lesions called polyps in patients without symptoms. The aim of screening is both to catch bowel cancers early -- making them easier to treat successfully -- and to prevent cancers by removing pre-cancerous polyps. Although timings vary across the UK, adults at a certain age are invited ...
1 Feb 2020 to 30 Apr 2023
Public Project Summary
